Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long LLY ETF

23.70
+1.577.09%
Pre-market: 24.420.7200+3.04%06:16 EST
Volume:670.62K
Turnover:15.64M
Market Cap:42.54M
PE:- -
High:23.75
Open:23.54
Low:22.61
Close:22.13
52wk High:28.44
52wk Low:9.60
Shares:1.80M
Float Shares:1.71M
Volume Ratio:0.63
T/O Rate:39.33%
Dividend:0.70
Dividend Rate:2.97%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

US STOCKS-Wall St futures muted as markets await key economic data

Reuters
·
1 hour ago

Eli Lilly Shares up 2.2% Premarket After Hims & Hers Withdraws Launch of Weight-Loss Pill

THOMSON REUTERS
·
2 hours ago

Strong Weight-Loss Drug Demand Fuels Optimistic Growth Outlook! Goldman Sachs Raises Eli Lilly Target to $1,260

Stock News
·
4 hours ago

Bristol Gate Capital Partners Trims Eli Lilly Stake

TIPRANKS
·
8 hours ago

INNOVENT BIO Shares Surge Over 4% on Strategic Collaboration with Eli Lilly Potentially Worth $8.85 Billion

Stock News
·
10 hours ago

Eli Lilly Earnings Call Highlights Hyper-Growth Momentum

TIPRANKS
·
11 hours ago

BREAKINGVIEWS-The Week in Breakingviews: Shooting for the moon

Reuters
·
11 hours ago

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Canopy Growth (CGC)

TIPRANKS
·
18 hours ago

Innovent Biologics announces collaboration with Lilly

TIPRANKS
·
Yesterday

INNOVENT BIO and Eli Lilly Form Global Strategic Alliance to Advance Oncology and Immunology Drug Development

Stock News
·
Yesterday

BRIEF-Eli Lilly Spokesperson Says No One Should Be Mass-Compounding Or Selling Knockoff Glp-1 Products Regardless Of How They’re Administered

Reuters
·
Yesterday

Eli Lilly Sokesperson: Look Forward to Decisive Steps FDA Has Announced It Will Take, and We Urge Other Regulators and Law Enforcement to Do the Same

THOMSON REUTERS
·
Yesterday

CORRECTED-Weight-loss drugs to compete on biggest stage with Super Bowl ads

Reuters
·
Feb 07

The Weight-Loss Price Wars Are Breaking Big Pharma's Business Model -- Heard on the Street -- WSJ

Dow Jones
·
Feb 07

TrumpRx Is Here. Most People Won't Benefit. -- Barrons.com

Dow Jones
·
Feb 07

Hims & Hers stock nears one-year low amid battle over compounded Wegovy pill

Dow Jones
·
Feb 07

CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder

Benzinga_recent_news
·
Feb 07

Novo Stock Jumps, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle. -- Barrons.com

Dow Jones
·
Feb 06

Novo Nordisk shares rebound as FDA targets illegal drug copies

Reuters
·
Feb 06

FDA Vows Crackdown on Unapproved Weight-Loss Drug Copies, Boosting Shares of Novo Nordisk and Eli Lilly

Stock News
·
Feb 06